Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland.
暂无分享,去创建一个
S. Crabb | Á. Benedict | V. Kapetanakis | A. Bullement | A. Amin | Ying Xiao | A. Eccleston | M. Kearney | Jane Chang | Robert Jones | Simone Critchlow | Katerina Christoforou